These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21929753)

  • 1. 2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome.
    Heywood WE; Madgett TE; Wang D; Wallington A; Hogg J; Mills K; Avent ND
    Proteome Sci; 2011 Sep; 9():56. PubMed ID: 21929753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
    Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and identification of potential predictive biomarkers for Down's syndrome from second trimester maternal serum.
    Yao Y; Jiang Y; Han M; Xia Y; He Y; Wang Y; Luo Y; Zhang B
    Expert Rev Proteomics; 2015 Feb; 12(1):97-107. PubMed ID: 25434962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.
    Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP
    Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of inflammation and innate immunity in atrophic nonunion fracture.
    de Seny D; Cobraiville G; Leprince P; Fillet M; Collin C; Mathieu M; Hauzeur JP; Gangji V; Malaise MG
    J Transl Med; 2016 Sep; 14(1):258. PubMed ID: 27599571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
    Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
    Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.
    Hsu TY; Lin H; Hung HN; Yang KD; Ou CY; Tsai CC; Cheng HH; Chung SH; Cheng BH; Wong YH; Chou AK; Hsiao CC
    PLoS One; 2016; 11(1):e0145908. PubMed ID: 26752631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.
    Lim JH; Kim SY; Park SY; Lee SY; Kim MJ; Han YJ; Lee SW; Chung JH; Kim MY; Yang JH; Ryu HM
    PLoS One; 2011; 6(11):e27709. PubMed ID: 22132128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer.
    Kakisaka T; Kondo T; Okano T; Fujii K; Honda K; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Yamada T; Kato H; Nishimura T; Todo S; Hirohashi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):257-67. PubMed ID: 17303479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
    Lehavi O; Aizenstein O; Evans MI; Yaron Y
    Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal.
    Scholl PF; Cole RN; Ruczinski I; Gucek M; Diez R; Rennie A; Nathasingh C; Schulze K; Christian P; Yager JD; Groopman JD; West KP
    Placenta; 2012 May; 33(5):424-32. PubMed ID: 22385826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ).
    Kolla V; Jenö P; Moes S; Tercanli S; Lapaire O; Choolani M; Hahn S
    J Biomed Biotechnol; 2010; 2010():952047. PubMed ID: 19902006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential biomarkers for Turner in maternal plasma: possibility for noninvasive prenatal diagnosis.
    Kolialexi A; Anagnostopoulos AK; Papantoniou N; Vougas K; Antsaklis A; Fountoulakis M; Mavrou A; Tsangaris GT
    J Proteome Res; 2010 Oct; 9(10):5164-70. PubMed ID: 20738094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.